INTELLIGENT BIO SOLUTIONS INC. (INBS)
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Intelligent Bio Solutions Inc.
Trials need funding. See this company's dilution risk and cash position.
- ObservationalUnknown status
PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine
Intelligent Fingerprinting Drug Screening System
Pharmacokinetics
NCT06519045Enrollment40StartJun 2024Primary CompletionAug 2024est.CompletionSep 2024est. - ObservationalUnknown status
Drug Screening System Method Comparison
Fingerprint sweat drug screen, Fingerprint sweat laboratory analysis
Reagent Kits, Diagnostic
NCT06618183Enrollment135StartAug 2024Primary CompletionNov 2024est.CompletionDec 2024est. - ObservationalRecruiting
Method Comparison of Intelligent Fingerprinting Drug Screening System
-
Drug Abuse Illicit
NCT07650136Enrollment144StartJun 2026Primary CompletionJul 2026est.CompletionAug 2026est. - ObservationalCompleted
Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Following Controlled, Oral Administration of Codeine Phosphate Tablets to 40 Healthy Adults
Determination of codeine phosphate
Healthy Adult
NCT07755267Enrollment43StartJan 2026Primary CompletionFeb 2026CompletionFeb 2026 - Not applicableCompleted
Usability Evaluation of the Intelligent Fingerprinting Drug Screening System
Diagnostic procedures, Drug Screening
Healthy Adult Participants
NCT07758777Enrollment45StartJul 2026Primary CompletionJul 2026CompletionJul 2026 - Not applicableEnrolling by invitation
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening System
Device storage condition, Interferent application
Interference With Routine Analytical Tests, Stability of in Vitro Diagnostic Reagents +1
NCT07758907Enrollment95StartJun 2026Primary CompletionAug 2026est.CompletionOct 2026est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Observational | Unknown status | Intelligent Fingerprinting Drug Screening System | NCT06519045 |
| Observational | Unknown status | Fingerprint sweat drug screen, Fingerprint sweat laboratory analysis | NCT06618183 |
| Observational | Recruiting | - | NCT07650136 |
| Observational | Completed | Determination of codeine phosphate | NCT07755267 |
| Not applicable | Completed | Diagnostic procedures, Drug Screening | NCT07758777 |
| Not applicable | Enrolling by invitation | Device storage condition, Interferent application | NCT07758907 |